OpenBCI is a US-based startup founded in 2014, specializing in open-source tools for neuroscience and biosensing. With the slogan "We make open-source tools for neuroscience & biosensing," the company has been at the forefront of developing hardware and software for accessible neurotechnology for over a decade. One of their flagship products, Galea, is an enterprise, multi-modal biosensing headset designed to interface with the human mind. This groundbreaking product combines high-fidelity AR/VR/XR display technology with comprehensive bio-sensing headwear, making it commercially available for the first time. The latest milestone for OpenBCI was a Venture Round investment at 15 December 2021, which attracted funding from prominent investors including BITKRAFT Ventures, NaHCO3, and re.Mind Capital. With a focus on novel BCI hardware and artificial intelligence, the company is dedicated to translating vast amounts of human physiological data into meaningful insights. Operating in the hardware industry, OpenBCI is positioned to continue driving innovation in the field of neurotechnology, leveraging its open-source approach and cutting-edge products.
No recent news or press coverage available for OpenBCI.